Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $2.82 billion. The enterprise value is $2.45 billion.
| Market Cap | 2.82B |
| Enterprise Value | 2.45B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 112.27 million shares outstanding. The number of shares has increased by 6.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 112.27M |
| Shares Change (YoY) | +6.01% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 66.21% |
| Float | 97.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.26 |
| Forward PS | 6.09 |
| PB Ratio | 4.64 |
| P/TBV Ratio | 5.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.13 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.13 |
Financial Efficiency
Return on equity (ROE) is -26.91% and return on invested capital (ROIC) is -17.90%.
| Return on Equity (ROE) | -26.91% |
| Return on Assets (ROA) | -14.75% |
| Return on Invested Capital (ROIC) | -17.90% |
| Return on Capital Employed (ROCE) | -40.87% |
| Weighted Average Cost of Capital (WACC) | 8.26% |
| Revenue Per Employee | $252,026 |
| Profits Per Employee | -$105,501 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.67 |
Taxes
| Income Tax | -2.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.95% in the last 52 weeks. The beta is 0.83, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -19.95% |
| 50-Day Moving Average | 22.33 |
| 200-Day Moving Average | 19.88 |
| Relative Strength Index (RSI) | 52.94 |
| Average Volume (20 Days) | 1,067,582 |
Short Selling Information
The latest short interest is 7.47 million, so 6.79% of the outstanding shares have been sold short.
| Short Interest | 7.47M |
| Short Previous Month | 6.53M |
| Short % of Shares Out | 6.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.80 |
Income Statement
In the last 12 months, Zai Lab had revenue of $449.61 million and -$188.21 million in losses. Loss per share was -$1.70.
| Revenue | 449.61M |
| Gross Profit | 16.99M |
| Operating Income | -264.10M |
| Pretax Income | -190.72M |
| Net Income | -188.21M |
| EBITDA | -248.17M |
| EBIT | -264.10M |
| Loss Per Share | -$1.70 |
Balance Sheet
The company has $617.52 million in cash and $254.58 million in debt, with a net cash position of $362.95 million or $3.23 per share.
| Cash & Cash Equivalents | 617.52M |
| Total Debt | 254.58M |
| Net Cash | 362.95M |
| Net Cash Per Share | $3.23 |
| Equity (Book Value) | 607.04M |
| Book Value Per Share | 5.41 |
| Working Capital | 485.45M |
Cash Flow
In the last 12 months, operating cash flow was -$133.38 million and capital expenditures -$6.19 million, giving a free cash flow of -$139.57 million.
| Operating Cash Flow | -133.38M |
| Capital Expenditures | -6.19M |
| Depreciation & Amortization | 15.93M |
| Net Borrowing | 53.38M |
| Free Cash Flow | -139.57M |
| FCF Per Share | -$1.24 |
Margins
Gross margin is 3.78%, with operating and profit margins of -58.74% and -41.86%.
| Gross Margin | 3.78% |
| Operating Margin | -58.74% |
| Pretax Margin | -42.42% |
| Profit Margin | -41.86% |
| EBITDA Margin | -55.20% |
| EBIT Margin | -58.74% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.01% |
| Shareholder Yield | -6.01% |
| Earnings Yield | -6.68% |
| FCF Yield | -4.96% |
Analyst Forecast
The average price target for Zai Lab is $33.14, which is 32.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.14 |
| Price Target Difference | 32.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 16.29% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of 0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 2 |